Endovascular Engineering ENGULF Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 177 participants.

Also called NCT05597891

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 177 participants (enrolled count) (from the registry)
Sponsor
Endovascular Engineering (from the registry)
Registry
  • NCT NCT05597891
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05597891. Allocation not applicable; no masking; primary purpose treatment. Start 2023-01-12 (actual); primary completion 2026-03-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Endovascular Engineering ENGULF Study
Acronym
ENGULF
Intervention (Device)
Hēlo PE Thombectomy System
Lead sponsor
Endovascular Engineering (class: industry)

Record details

Record id
cardio:ct-nct05597891
Content hash
171fecace0f359cfe264c2f1d3a76e12b2977add2c398696b2778b2602801ca4